SCHEMBL22150288

SCHEMBL22150288

CCNc1nc(SC)ncc1C=CC#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
PGK1 P00558 1/20 0.35
ALDH1A1 P00352 1/20 0.34
SYK P43405 1/20 0.31
HTT P42858 1/20 0.31
LRRK2 Q5S007 1/20 0.31
MAP3K7 O43318 2/20 0.30
TAB1 Q15750 2/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA7 P43166 1/20 0.30
CA13 Q8N1Q1 1/20 0.30
CTSV O60911 1/20 0.30
CTSL P07711 1/20 0.30
CTSH P09668 1/20 0.30
CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16120621 1.00 KDM4E (0.39) KDM4EPGK1ALDH1A1SYKHTT
SCHEMBL16094324 0.89 ALDH1A1 (0.38) KDM4EALDH1A1SYKHTTCYP1A2
SCHEMBL16120614 0.89 ALDH1A1 (0.38) KDM4EALDH1A1SYKHTTCYP1A2
SCHEMBL16100026 0.85 ALDH1A1 (0.35) KDM4EALDH1A1HTTCYP1A2CYP3A4
SCHEMBL16100027 0.85 ALDH1A1 (0.35) KDM4EALDH1A1HTTCYP1A2CYP3A4
SCHEMBL4712741 0.84 KDM4E (0.39) KDM4EHTT
SCHEMBL16120492 0.84 KDM4E (0.39) KDM4EHTT
SCHEMBL16094336 0.83 PPARG (0.34) KDM4ELRRK2CYP3A4CYP2D6
SCHEMBL16094337 0.83 PPARG (0.34) KDM4ELRRK2CYP3A4CYP2D6
SCHEMBL16094328 0.81 KDM4E (0.36) KDM4EMAP3K7TAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733184-B1 PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ICAHN SCHOOL MED MOUNT SINAI (US) 2023-08-30 EP claimed
EP-2968331-B1 PYRIMIDINE COMPOUNDS AS KINASE INHIBITORS ICAHN SCHOOL MED MOUNT SINAI (US) 2020-07-01 EP claimed
EP-3733184-A1 PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Icahn School of Medicine at Mount Sinai (US) 2020-11-04 EP disclosed